130 related articles for article (PubMed ID: 22782858)
41. Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
Welti J; Loges S; Dimmeler S; Carmeliet P
J Clin Invest; 2013 Aug; 123(8):3190-200. PubMed ID: 23908119
[TBL] [Abstract][Full Text] [Related]
42. Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia.
Sarkar C; Chakroborty D; Dasgupta PS; Basu S
Int J Cancer; 2015 Aug; 137(3):744-9. PubMed ID: 25556636
[TBL] [Abstract][Full Text] [Related]
43. The history of the angiogenic switch concept.
Ribatti D; Nico B; Crivellato E; Roccaro AM; Vacca A
Leukemia; 2007 Jan; 21(1):44-52. PubMed ID: 16990761
[TBL] [Abstract][Full Text] [Related]
44. Overview of angiogenesis: Biologic implications for antiangiogenic therapy.
Ellis LM; Liu W; Ahmad SA; Fan F; Jung YD; Shaheen RM; Reinmuth N
Semin Oncol; 2001 Oct; 28(5 Suppl 16):94-104. PubMed ID: 11706401
[TBL] [Abstract][Full Text] [Related]
45. Role of the tumor stroma in resistance to anti-angiogenic therapy.
Huijbers EJ; van Beijnum JR; Thijssen VL; Sabrkhany S; Nowak-Sliwinska P; Griffioen AW
Drug Resist Updat; 2016 Mar; 25():26-37. PubMed ID: 27155374
[TBL] [Abstract][Full Text] [Related]
46. Angiogenesis in spontaneous tumors and implications for comparative tumor biology.
Benazzi C; Al-Dissi A; Chau CH; Figg WD; Sarli G; de Oliveira JT; Gärtner F
ScientificWorldJournal; 2014; 2014():919570. PubMed ID: 24563633
[TBL] [Abstract][Full Text] [Related]
47. Chromosomal Instability Affects the Tumorigenicity of Glioblastoma Tumor-Initiating Cells.
Godek KM; Venere M; Wu Q; Mills KD; Hickey WF; Rich JN; Compton DA
Cancer Discov; 2016 May; 6(5):532-45. PubMed ID: 27001151
[TBL] [Abstract][Full Text] [Related]
48. Proteins and Molecular Pathways Relevant for the Malignant Properties of Tumor-Initiating Pancreatic Cancer Cells.
Samonig L; Loipetzberger A; Blöchl C; Rurik M; Kohlbacher O; Aberger F; Huber CG
Cells; 2020 Jun; 9(6):. PubMed ID: 32503348
[TBL] [Abstract][Full Text] [Related]
49. A therapy inactivating the tumor angiogenic factors.
Morales-Rodrigo C
Math Biosci Eng; 2013 Feb; 10(1):185-98. PubMed ID: 23311368
[TBL] [Abstract][Full Text] [Related]
50. Matrix regulation of tumor-initiating cells.
Wong SY; Kumar S
Prog Mol Biol Transl Sci; 2014; 126():243-56. PubMed ID: 25081621
[TBL] [Abstract][Full Text] [Related]
51. Development of a novel in vitro human tissue-based angiogenesis assay to evaluate the effect of antiangiogenic drugs.
Woltering EA; Lewis JM; Maxwell PJ; Frey DJ; Wang YZ; Rothermel J; Anthony CT; Balster DA; O'Leary JP; Harrison LH
Ann Surg; 2003 Jun; 237(6):790-8; discussion 798-800. PubMed ID: 12796575
[TBL] [Abstract][Full Text] [Related]
52. A new in vitro assay for human tumor angiogenesis: three-dimensional human tumor angiogenesis assay.
Gulec SA; Woltering EA
Ann Surg Oncol; 2004 Jan; 11(1):99-104. PubMed ID: 14699041
[TBL] [Abstract][Full Text] [Related]
53. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch.
Naumov GN; Akslen LA; Folkman J
Cell Cycle; 2006 Aug; 5(16):1779-87. PubMed ID: 16931911
[TBL] [Abstract][Full Text] [Related]
54. Dynamic fluorescence imaging for multiparametric measurement of tumor vasculature.
Choi M; Choi K; Ryu SW; Lee J; Choi C
J Biomed Opt; 2011 Apr; 16(4):046008. PubMed ID: 21529077
[TBL] [Abstract][Full Text] [Related]
55. Modulation of immunity by antiangiogenic molecules in cancer.
Terme M; Colussi O; Marcheteau E; Tanchot C; Tartour E; Taieb J
Clin Dev Immunol; 2012; 2012():492920. PubMed ID: 23320019
[TBL] [Abstract][Full Text] [Related]
56. Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells.
Afkhami F; Durocher Y; Prakash S
J Biomed Biotechnol; 2010; 2010():645610. PubMed ID: 20976076
[TBL] [Abstract][Full Text] [Related]
57. New ex-ovo colorectal-cancer models from different SdFFF-sorted tumor-initiating cells.
Mélin C; Perraud A; Christou N; Bibes R; Cardot P; Jauberteau MO; Battu S; Mathonnet M
Anal Bioanal Chem; 2015 Nov; 407(28):8433-43. PubMed ID: 26427501
[TBL] [Abstract][Full Text] [Related]
58. 18F‑alfatide positron emission tomography may predict anti‑angiogenic responses.
Liu J; Wang D; Meng X; Sun X; Yuan S; Yu J
Oncol Rep; 2018 Nov; 40(5):2896-2905. PubMed ID: 30226599
[TBL] [Abstract][Full Text] [Related]
59. Angiogenesis and apoptosis.
Folkman J
Semin Cancer Biol; 2003 Apr; 13(2):159-67. PubMed ID: 12654259
[TBL] [Abstract][Full Text] [Related]
60. Antiangiogenic therapy.
Albo D; Wang TN; Tuszynski GP
Curr Pharm Des; 2004; 10(1):27-37. PubMed ID: 14754403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
